Carrillo-Palau, M.; Hernández-Camba, A.; Ramos, L.; Vela, M.; Arranz, L.; Hernández Alvarez-Buylla, N.; Alonso-Abreu, I.; Hernández-Pérez, A.; Hernández-Guerra, M.; Palazuelos, C.;
et al. QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease. J. Clin. Med. 2021, 10, 4102.
https://doi.org/10.3390/jcm10184102
AMA Style
Carrillo-Palau M, Hernández-Camba A, Ramos L, Vela M, Arranz L, Hernández Alvarez-Buylla N, Alonso-Abreu I, Hernández-Pérez A, Hernández-Guerra M, Palazuelos C,
et al. QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine. 2021; 10(18):4102.
https://doi.org/10.3390/jcm10184102
Chicago/Turabian Style
Carrillo-Palau, Marta, Alejandro Hernández-Camba, Laura Ramos, Milagros Vela, Laura Arranz, Noemi Hernández Alvarez-Buylla, Inmaculada Alonso-Abreu, Anjara Hernández-Pérez, Manuel Hernández-Guerra, Camilo Palazuelos,
and et al. 2021. "QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease" Journal of Clinical Medicine 10, no. 18: 4102.
https://doi.org/10.3390/jcm10184102
APA Style
Carrillo-Palau, M., Hernández-Camba, A., Ramos, L., Vela, M., Arranz, L., Hernández Alvarez-Buylla, N., Alonso-Abreu, I., Hernández-Pérez, A., Hernández-Guerra, M., Palazuelos, C., Llorca, J., González-Gay, M. Á., & Ferraz-Amaro, I.
(2021). QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine, 10(18), 4102.
https://doi.org/10.3390/jcm10184102
